期刊文献+

CXCL12/CXCR4生物轴在头颈部鳞癌淋巴转移的作用 被引量:4

The relationship between CXCL12/CXCR4 biological axis and neck lymphatic metastasis in head and neck squamous carcinoma
原文传递
导出
摘要 目的 观察趋化因子受体4(CXCR4)及其配体12(CXCL12)在头颈部鳞癌(HNSCC)组织及颈部淋巴结中的表达,分析CXCR4、CXCL12的表达与HNSCC临床病理关系,探讨CXCL12/CXCR4生物轴在HNSCC淋巴转移中的作用.方法 半定量逆转录.聚合酶链反应(RT-PCR法)及免疫组织化学SP法检测65例HNSCC组织、15例正常口腔组织及良性病变中CXCR4、CXCL12基因及蛋白表达.结果 RT-PCR结果:CXCR4在鳞癌转移组、非转移组、良性对照组中的表达分别为0.406±0.044、0.464±0.068、0.900±0.108,各组间表达的差异有统计学意义(P〈0.05).转移组、未转移组淋巴结中CXCL12的表达分别为0.935±0.087、0.861±0.047,差异无统计学意义(P〉0.05).免疫组织化学结果:CXCR4在鳞癌转移组、非转移组、良性对照组中的表达率分别为71.4%、33.3%、13.3%.各组间表达的差异有统计学意义(X2=65.23,P〈0.05).CXCR4的表达与临床分期、肿瘤分化程度、淋巴结转移显著相关(P〈0.01),与年龄、性别无明显相关(P〉0.05).淋巴结中高表达CXCL12,CXCL12的表达在所有参数的分组表达中差异均无统计学意义(P〉0.05).结论 CXCR4的高表达可能赋予HNSCC细胞较强的局部侵犯及淋巴转移潜能 CXCL12/CXCR4生物轴在HNSCC淋巴转移中可能发挥作用. Objective To analyze the relationship between the expression of CXCR4 and CXCL12 in head and neck squamous carcinoma(HNSCC) and clinicopathological features of HNSCC, and explore the effect of CXCR4/CXCL12 biological axis on lymph node metastasis in HNSCC. Methods The clinicopathological data of 65 patients with HNSCC undergoing surgical resection were collected and reviewed. Fifteen cases of normal mucosa and benign lesion served as controls. The differential expression of CXCR4 and CXCL12 in different groups was detected by using immunohistochemical staining and reverse transcrip-tion-polymerase chain reaction(RT-PCR) to identify their relationship with lymph node metastasis. Results The expression of CXCR4 mRNA was 0.406 ± 0. 044, 0.464 ± 0. 068 and 0. 900 ± 0. 108 in lymp metastasis, non-lymph metastasis and control groups respectively. There was significant difference in the CXCR4 mRNA expression between HNSCC group and control group (P〈0.05). The CXCL12 mRNA expression was 0. 935 ± 0.087 and 0. 861±0.047 in lymp metastasis and non-metastasis groups (P〉0.05 ). The statistical analysis revealed that the expression rate of CSCR4 protein was 71.4% (25/35), 33. 3% (10/30) and 13.3% (2/15) in lymph metastasis, non-metastasis and control groups respectively. Over-expression of CXCR4 was significantly correlated with clinical stage, depth of invasion and lymph node metastasis (P〈0.01). There was no significant difference in the CXCL12 expression among the groups. Conclusion Overexpression of CXCR4 was related to lymph node metastasis and classification in HNSCC. CXCL12/CXCR4 biological axis might promote orientation metastasis to cervical lymph node in HNSCC.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2010年第7期992-994,F0004,共4页 Chinese Journal of Experimental Surgery
基金 基金项目:天津市高等学校科技发展基金资助项目(20050222)
关键词 头颈部鳞癌 淋巴转移 Head and neck squamous carcinoma Lymphatic metastasis
  • 相关文献

参考文献8

  • 1Kowalski LP,Bagietto R,Lara JR,et al.Prognostic significance of the distribution of neck node metastasis from oral carcinoma.Head Neck,2000,22:207-214.
  • 2Rubin JB,Kung AI,Kiein RS,et al.A small molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors.Prm Natl Afacl Sti USN.2003,100:13513-13518.
  • 3Viola A,Luster AD.Chemokines and their recaptors:drug targets in immunity and inflammation.Annu Rev Pharmacol Toxicol,2008,48:171-197.
  • 4Singh S,Sadanandam A,Singh RK.Chemokines in tumor angiogenesis and metastasis.Cancer Metastasis Rev,2007,26:453-467.
  • 5马向涛,余力伟,王杉,杜如昱,崔志荣.结直肠癌淋巴结转移与趋化因子受体CXCR4/CXCL12信号转导通路的关系[J].中华实验外科杂志,2007,24(1):60-61. 被引量:24
  • 6Muller A,Homey B,Soto H,et al.Involvement of chemokine recaptors in breast cancer metastasis.Nature,2001,410:50-56.
  • 7张霖,史玉荣,魏熙胤,杨毅,牛瑞芳,姚智.趋化因子受体4下调抑制乳腺癌转移的研究[J].中华实验外科杂志,2007,24(11):1401-1403. 被引量:9
  • 8Sauvé K,LePage J,Sanchez M,et al.Positive feedback activation of estrogen recaptors by the CXCL12/CXCR4 pathway.Cancer Res,2009,69:5793-5800.

二级参考文献12

共引文献29

同被引文献26

  • 1马向涛,余力伟,王杉,杜如昱,崔志荣.结直肠癌淋巴结转移与趋化因子受体CXCR4/CXCL12信号转导通路的关系[J].中华实验外科杂志,2007,24(1):60-61. 被引量:24
  • 2尹扬光,黄岚,赵晓辉,于世勇,方玉强,赵景红.SDF-1对内皮祖细胞增殖迁移的影响及AMD3100对其的干预[J].第三军医大学学报,2007,29(6):475-478. 被引量:11
  • 3JIANG Yu-ping,WU Xiao-hua,XING Han-ying,DU Xing-yan.Role of CXCL12 in metastasis of human ovarian cancer[J].Chinese Medical Journal,2007(14):1251-1255. 被引量:12
  • 4Barbieri F, Thellung S, Wurth R, et al. Emerging targets in pituitary adenomas :role of the CXCL12/CXCR4-R7 system[ J]. Int J Endocri- nol,2014,2014:753524.
  • 5Doring Y, Pawig L, Weber C, et al. The CXCL12/CXCR4 chemokine ligand/receptor axis in cardiovascular disease [ J ]. Front Physiol, 2014,5(6) :212.
  • 6Lombardi L, Tavano F, Morelli F, et al. Chemokine receptor CXCR4 : role in gastrointestinal cancer[ J ]. Crit Rev Oncol Hematol,2013,88 ( 3 ) :696-705.
  • 7Rainczuk A, Rao JR, Gathercole JL, et al. Evidence for the antagonis- tic form of CXC-motif chemokine CXCLIO in serous epithelial ovarian tumours[ J]. Int J Cancer,2014,134 ( 3 ) :530-541.
  • 8Sarvaiya PJ, Guo D, Ulasov I, et al. Chemokines in tumor progression and metastasis[J]. Oncotarget,2013,4(12) :2171-2185.
  • 9Lv S, Yang Y, Kwon S, et al. The association of CXCR4 expression with prognosis and clinicopathological indicators in colorectal carcino- ma patients : a meta-analysis [ J ]. Histopathology, 2014,64 ( 5 ) : 701- 712.
  • 10Torregrossa L, Giannini R, Borrelli N, et al. CXCR4 expression corre- lates with the degree of tumor infiltration and BRAF status in papillary thyroid carcinomas[ J]. Mod Patho1,2012,25 (1) :46-55.

引证文献4

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部